The Nobel assembly at the Karolinska Institute in Stockholm announced three laureates as recipients of the 2026 Nobel Prize in Physiology or Medicine. Karl Deisseroth of the Howard Hughes Medical Institute and Stanford University, Peter Hegemann of the Humboldt University of Berlin, and Georg Nagel of the University of Würzburg were honored for their discoveries related to light-gated ion channels and optogenetics. Each researcher will receive an equal share of 12 million Swedish kronor, approximately £900,000.
The foundational work originated from Hegemann’s investigation into how a green alga navigates toward light by identifying light-sensitive proteins in its eye spot. Subsequently, Hegemann and Nagel identified channelrhodopsins—proteins that respond to blue light by allowing ions to flow into cells and generate electrical impulses. When genetic instructions for these proteins were introduced into kidney cells in laboratory studies, the cells became light-sensitive.
Deisseroth extended these findings by demonstrating that introducing channelrhodopsin genes into nerve cells in living animal brains enabled researchers to trigger electrical signals using light delivered through tiny optical fibers. This approach has been applied to map neural circuits controlling movement, memory formation, and fear responses in mice. The technique now enables researchers to establish cause-and-effect relationships between specific brain cells and behavioral outcomes.
Beyond basic research applications, optogenetics has advanced into clinical medicine. In a notable trial, the genetic instructions for channelrhodopsins were delivered to retinal cells in a blind patient with retinitis pigmentosa. Combined with specialized goggles that converted visual information into light pulses, this approach partially restored the patient’s sight. Experts anticipate the recognition of these discoveries will accelerate development of optogenetic therapies for neurological and psychiatric disorders, including dementia, epilepsy, and addiction by clarifying which neural systems malfunction in disease states.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI